Kaouthar Louati | Neuroscience | Excellence in Research Award

Dr Kaouthar Louati, University of Monastir, Tunisia

Dr. Kaouthar Louati is a distinguished researcher and analytical chemist 🎓🧪 with a doctoral degree in Analytical Chemistry from the University of Monastir, Tunisia 🇹🇳. She has made substantial contributions to pharmaceutical sciences through over 15 high-impact publications 📚, two book contributions 📘, and collaborative projects in Tunisia and the UK 🇬🇧. Her work focuses on toxicoproteomics, redox proteomics, and stability studies of pharmaceuticals 💊. Dr. Louati is affiliated with prestigious institutions including the University of Nottingham, Habib Bourguiba University Hospital, and multiple pharmaceutical laboratories 🏥🔬. Known for her meticulous method validation, drug impurity analysis, and environmental toxicology studies 🌿⚗️, she has emerged as a key figure in analytical method development and toxicological risk assessment. With deep academic commitment and a passion for pharmaceutical innovation 💡, she continues to impact the global scientific community and serves as a role model for women in STEM 👩‍🔬🌍.

Publication Profile

Orcid

Education

Dr. Louati’s academic journey is rooted in excellence 🌟. She earned her Doctorate in Analytical Chemistry (2019–2024) 🧪 from the University of Monastir, Tunisia, with very honorable distinction 🎓. Previously, she completed a Master’s in Medicaments’ Research and Development (2009–2010) 🧬 and a Diploma in Doctor of Pharmacy (2008–2009), both with high honors 🏅. Her early academic path included a Diploma in Pharmacy (2002–2007) with a very good grade 🧑‍⚕️ and a Mathematics Baccalaureate (2002) with very honorable mention 🧠➕➖. Throughout her education, she displayed strong scientific aptitude, particularly in pharmaceutical formulation, analytical chemistry, and medical science fundamentals 💉📘. This rich academic foundation positioned her to excel in multidisciplinary pharmaceutical research, bridging clinical applications with laboratory innovation 🧫🔍.

Experience

Dr. Louati has extensive experience in academia, hospitals, and the pharmaceutical industry 🏥🏭. Since 2020, she has served as a Doctor Pharmacist and Associate Researcher at the University of Monastir’s Laboratory of Pharmacology and Drug Development 🔬, and at the Habib Bourguiba University Hospital in both the pharmaceutical and pathological anatomy departments 🧑‍⚕️🧫. She also contributed internationally at the University of Nottingham and Royal Derby Hospital, UK (2020–2023) 🇬🇧. From 2010 to 2015, she worked in UNIMED and PHARMACARE Laboratories, where she developed generic drugs, validated analytical methods, and ensured product compliance with international pharmacopeias 💊📈. Her expertise spans method validation (ICH Q2R1), stress testing, impurity profiling, and regulatory documentation ✍️📑. Her collaborative approach and technical leadership across diverse settings underscore her excellence as both a researcher and pharmaceutical scientist 🌍🧪.

Awards and Honors

Dr. Kaouthar Louati has earned academic distinction throughout her career, including “Very Honorable” mentions for both her doctoral and master’s studies 🏅📘. She was recognized for producing highly cited research and has published over 15 peer-reviewed articles and 2 books in respected international journals and editions 📚🌐. Her contributions to method development, toxicological evaluation, and environmental health have received national and international attention 🧬🌍. Her scientific rigor earned her opportunities to collaborate with global institutions such as the University of Nottingham, reflecting peer recognition and trust in her expertise 🤝🔬. Her work on toxicoproteomics and pharmaceutical impurities has made significant impacts on public health research and regulatory science 🌡️⚗️. Dr. Louati’s continued academic excellence, innovation, and mentorship potential position her as a prime candidate for the Best Researcher Award 🏆🎖️.

Research Focus

Dr. Louati’s research is at the forefront of analytical chemistry, toxicoproteomics, and pharmaceutical sciences 🔍🧪. She focuses on validating and developing robust analytical methods to detect drug impurities, residual solvents, and degradation products, essential for drug stability and safety studies 💊📈. Her work in toxicoproteomics includes assessing oxidative stress and protein damage induced by environmental toxins like pesticides using cutting-edge techniques like Nano-UHPLC-MS/MS and 2D-SDS-PAGE 🌿🧬. She also pioneers method development for anti-epileptic drug monitoring and anabolic steroid detection for doping control 🧠💪. Her integration of redox biology and pharmacological analytics strengthens both environmental health surveillance and clinical pharmacology 🌎🏥. Dr. Louati’s unique blend of expertise bridges fundamental research with real-world applications, significantly contributing to public health, pharmacovigilance, and regulatory standards 🌐📊.

Publication Top Notes

A Shotgun Proteomic-Based Approach with a Q-Exactive Hybrid Quadrupole-Orbitrap High-Resolution Mass Spectrometer for the Assessment of Pesticide Mixture-Induced Neurotoxicity on a 3D-Developed Neurospheroid Model from Human Brain Meningiomas: Identification of Trityl-Post-Translational Modification

Differential Proteome Profiling Analysis under Pesticide Stress by the Use of a Nano-UHPLC-MS/MS Untargeted Proteomic-Based Approach on a 3D-Developed Neurospheroid Model: Identification of Protein Interactions, Prognostic Biomarkers, and Potential Therapeutic Targets in Human IDH Mutant High-Grade Gliomas

Research of Pesticide Metabolites in Human Brain Tumor Tissues by Chemometrics-Based Gas Chromatography–Mass Spectrometry Analysis for a Hypothetical Correlation between Pesticide Exposure and Risk Factor of Central Nervous System Tumors

Evaluation of the reliability of human teeth matrix used as a biomarker for fluoride environmental pollution

Optimization of morphine extraction method for the assay of its urinary 3-glucuronideconjuguate by gas chromatography-mass spectrometry

Development of a new stability indicating method for the simultaneous separation of voriconazole from its impurities along with sodium benzoate used as a preservative in a powder for oral suspension

Development of a new liquid chromatographic method for the simultaneous separation of ciprofloxacin degradation products with 5-hydroxymethyl-furfural, impurity of D-glucose, in an intravenous solution for perfusion

Margaret Boone Rappaport | Neuroscience | Hypothesis Achievement Award

Dr Margaret Boone Rappaport, The Human Sentience Project, LLC, United States

Dr. Margaret Rappaport is a seasoned program evaluator and policy analyst, specializing in health and social services. She has extensive experience with Federal, State, and local programs, notably with the US Census Bureau. Her expertise spans quantitative and qualitative methodologies, including multivariate statistical techniques and field research. Margaret’s career highlights include work on substance abuse program evaluation, cognitive interviewing, and managing large datasets. She has authored studies and provided consultancy for numerous agencies and organizations, focusing on program effectiveness and data quality. Margaret continues to contribute actively to research and evaluation in her field. 📊

Education

In 1968, I earned my B.A. in Biology from George Washington University, embarking on a journey of academic pursuits. This was followed by an M.Ed. in Social Foundations of Education from the University of Florida in 1970, laying a solid groundwork for my educational career. Subsequently, I pursued Anthropology, obtaining an M.A. in 1975 and a Ph.D. in Cultural Anthropology in 1977 from Ohio State University, delving deep into cultural studies. Later, in 1979 and 1985, I enriched my expertise with coursework in Statistics and Advanced SAS at George Washington University. Finally, in 1990 and 1992, I engaged in Environmental Biology coursework at George Mason University, broadening my knowledge 📚.

Experience

From 1988 to 2007, as President of POLICY RESEARCH METHODS, INCORPORATED (PRMI), I led diverse projects focused on evaluation and research for prominent clients such as the U.S. Census Bureau, HUD, and various nonprofit organizations. My responsibilities ranged from conducting cognitive interviews on census questions to evaluating programs like transitional housing and substance abuse rehabilitation. I also facilitated grants review and developed methodologies for assessing program effectiveness. Transitioning to independent consulting from 2008 to 2010 with AMATEA LLC, I specialized in business development and proposal writing, leveraging extensive experience in research and evaluation across multiple sectors. 📊

Honors

Dr Margaret Boone Rappaport ‘s scholarly achievements have been recognized through prestigious memberships in honor societies like Phi Beta Kappa and Phi Kappa Phi. Her exemplary work earned her accolades such as the Praxis Award from the Washington Association of Professional Anthropologists. These honors underscore her academic prowess and dedication to advancing anthropological research and practice.

Presentations

A frequent presenter at leading conferences such as the American Anthropological Association and the Society for Applied Anthropology, Dr Margaret Boone Rappaport has consistently contributed groundbreaking insights. Her presentations on topics ranging from cultural ecology to health policy underscore her interdisciplinary approach and commitment to knowledge dissemination.

Publication Legacy 📚

Dr Margaret Boone Rappaport has authored several seminal books and numerous articles that delve into critical societal issues. Her publications, including “Capital Cubans” and “Capital Crime: Black Infant Mortality in America,” reflect her deep-seated commitment to addressing social inequalities through rigorous anthropological inquiry. Her research has notably influenced policy and practice, making her a pivotal figure in the field of applied anthropology.

Research focus

Dr. M.B. Rappaport’s research focuses on the intersection of theology, ethics, and space exploration, with a particular emphasis on the ethical implications of human expansion beyond Earth. Their work delves into ecotheology, exploring how religious principles can inform humanity’s approach to settling different celestial bodies—from the inner planets to the outer reaches of our solar system. They also investigate moral questions surrounding extraterrestrial intelligence (ETI) and the ethical frameworks necessary for future space colonization. Through their publications, Rappaport contributes to discussions on sustainability, morality, and the theological dimensions of space exploration. 🌌🛰️